5AM Ventures’ Post

View organization page for Artiva Biotherapeutics, graphic

9,793 followers

3mo

We are pleased to announce the pricing of an upsized $167.0 million initial public offering on the Nasdaq exchange. Read the release here: https://lnkd.in/gcTfTMJt #biotech #IPO #AlloNK #lupus #NKcell #NKcelltherapy #autoimmunedisease

22 Comments

Jessica Yingling

Biotech PR and Thought Leadership

3mo

Congrats to the Artiva team - it’s been so great to see you grow from founding to this important milestone!

1 Reaction

Ken Song

3mo

Congratulations to Fred Aslan, Jennifer Bush, Neha Krishnamohan and the rest of the Artiva team!

4 Reactions

Angie You

3mo

Huge congrats Fred Aslan and Neha Krishnamohan - excited to see the impact you'll have on patients

Brian Daniels

Partner at 5AM Venture

3mo

Congratulations to the Artiva team.

Anders Holm

COO & Head of Business Development at Zelluna Immunotherapy

3mo

Congratulations to the Artiva team! Well done!

Jake Couldrick

Co-Founder & Operations Director at Elixir Associates

3mo

Congratulations Artiva Biotherapeutics & Fred Aslan

Oksana Kryvenchuk

Life Sciences | B2B Marketing & Strategy

2mo

Great news! Congratulations to Artiva Biotherapeutics!

Gareth Sexton

Applying Advanced Analytical Methods to Recombinant Biologics, Cell and Gene Therapies

3mo

Congrats Artiva team!

Anne Marie Robinson, CCRA

Associate Director of Clinical Operations

3mo

Big congratulations to the Artiva team!

Brandon Marsh

Senior Director, Corporate Counsel at Sage Therapeutics

2mo

Congrats Artiva team!

See more comments

To view or add a comment, sign in

More Relevant Posts

5AM Ventures

19,888 followers
2w
Report this post
Congratulations Lifordi Immunotherapeutics, Inc.!

Lifordi Immunotherapeutics, Inc.

210 followers
2w

Lifordi is Honored to be Named a Winner of Endpoints 11 as Developer of Antibody Drug Conjugates for Autoimmune and Inflammatory Diseases. Read the Press Release Here: https://lnkd.in/eH5VQYTT

Lifordi Named Winner of Endpoints 11 as Developer of Antibody Drug Conjugates for Autoimmune and Inflammatory Diseases

lifordi.reportablenews.com

2 Comments
Like Comment
To view or add a comment, sign in
5AM Ventures

19,888 followers
3w
Report this post
Attention #biotech entrepreneurs and researchers! Don’t miss your chance to pitch your #startup ideas at #Science2Startup 2025 to top biotech and #pharma executives, VCs, and entrepreneurs in the Boston area. Applications are due Friday, November 15th: https://lnkd.in/e7bPwMzX
Like Comment
To view or add a comment, sign in
5AM Ventures

19,888 followers
3w
Report this post
Are you interested in building and investing in the next generation of innovative life science companies? We are now accepting applications for the January – June 2025 5AM Fellowship in our Boston office. 5AM Ventures' fellowship program provides participants with a hands-on experience and integrates fellows with active deal teams across modalities and therapeutic areas. We are seeking Fellows with strong scientific or medical background (MD and/or PhD) e.g., PhD students, MBA students with relevant experience, postdocs, and clinical fellows. Additional details and application instructions can be found at https://bit.ly/4evIqO2
3 Comments
Like Comment
To view or add a comment, sign in

19,888 followers

View Profile Follow

5AM Ventures’ Post

More Relevant Posts

Explore topics